This combination includes Pantoprazole 40 mg, a proton pump inhibitor, and Levosulpiride 75 mg (SR), a prokinetic agent, used for managing GERD, dyspepsia, and functional dyspepsia with associated motility disorders. It helps reduce gastric acid secretion and enhances gastrointestinal motility under medical supervision.